Related references
Note: Only part of the references are listed.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre
Alessandra Morano et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study
T. Nishida et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial
Kimford J. Meador et al.
EPILEPSIA (2016)
Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety
Lieven Lagae et al.
EPILEPSIA (2016)
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
V. Villanueva et al.
EPILEPSY RESEARCH (2016)
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
Alexandra Rohracher et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Psychosocial aspects of epilepsy: a wider approach
Marco Mula et al.
BJPSYCH OPEN (2016)
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial
Jacqueline A. French et al.
NEUROLOGY (2015)
First clinical experiences with perampanel-The Kork experience in 74 patients
Bernhard J. Steinhoff et al.
EPILEPSIA (2014)
Adverse effects and safety profile of perampanel: A review of pooled data
Fergus Rugg-Gunn
EPILEPSIA (2014)
Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
Warrington W. Q. Hsu et al.
CNS DRUGS (2013)
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305
Jacqueline A. French et al.
EPILEPSIA (2013)
Tolerability and safety of perampanel: two randomized dose-escalation studies
G. L. Krauss et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Randomized phase III study 306 Adjunctive perampanel for refractory partial-onset seizures
G. L. Krauss et al.
NEUROLOGY (2012)
The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: A systematic review and indirect comparison
Marrissa Martyn-St James et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada et al.
EPILEPSIA (2011)
Central nervous system adverse effects of new antiepileptic drugs - A meta-analysis of placebo-controlled studies
G. Zaccara et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
Share Paper
